Skip to content

Raystation

by Raysearch Laboratories AB 3 variants

510(k) K120387

Raystation is a Class II device made by Raysearch Laboratories AB, cleared under FDA 510(k) K120387 on 6 Apr 2012, active as of 22 Oct 2026. 6 FDA recalls are linked to it.

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None ongoing

6 closed

Documents

Trust

Unverified

Source FDA 510(k), synced 22 Oct 2026.

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK120387 Date6 Apr 2012ClearedStatusActive

Official records

Recalls

6 recalls · FDA

    • Terminated Z-1679-2015 FDA Class II initiated 8 May 2015

    RaySearch Laboratories AB became aware of an issue with the dose calculation for some imported VMAT plans where controls points are defined with wide gantry angle spacing.

    • Terminated Z-1481-2014 FDA Class II initiated 14 Feb 2014

    RaySearch Laboratories has recalled "RaySearch Ray Station 2.0, 2.5, 3.0, 3.5 and 4.0" software due to dose miscalculations for bolus/external/fixation support structures on CT-image.

    • Terminated Z-1307-2014 FDA Class II initiated 6 Feb 2014

    Potential for dose errors due to software program errors.

    • Terminated Z-0281-2014 FDA Class II initiated 23 Oct 2013

    Ray Search Laboratories found an issue with the dose calculation for Elekta motorized wedges in Ray Station 3.0, 3.5 and 4.0. The error presents when a wedge is used for a beam and the wedge angle differs from 60 degrees.

    • Terminated Z-1419-2013 FDA Class II initiated 15 Feb 2013

    Under some circumstances, imported CT, MR and PET images are offset from their true positions by one pixel in one or two directions. Users must be aware of this information to avoid incorrect dose calculations during treatment planning.

    • Terminated Z-2324-2012 FDA Class II initiated 9 May 2012

    The firm decided to recall when an issue was found with the dose calculation in RayStation 2.5, Raystation 2.5.1. The problem has not caused any patient mistreatment or other incidents. However, the user must be aware of this information to avoid incorrect dose calculations during treatment planning. The dose calculation is not correctly normalized in the unusual case of preventing the optimizatio

Timeline

7 dated events

  1. Cleared FDA 510(k) K120387
  2. Recall initiated FDA recalls Z-2324-2012
  3. Recall initiated FDA recalls Z-1419-2013
  4. Recall initiated FDA recalls Z-0281-2014
  5. Recall initiated FDA recalls Z-1307-2014
  6. Recall initiated FDA recalls Z-1481-2014
  7. Recall initiated FDA recalls Z-1679-2015

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA product code
MUJ
Device class
Class II
Regulation
21 CFR Part 892.5050
Advisory committee
Radiology
FDA decision
SESE Substantially Equivalent

Similar devices

Other devices filed under FDA product code MUJ (System, Planning, Radiation Therapy Treatment).

Other devices from Raysearch Laboratories AB

  • Raystation Version 1.0

    Class II
  • Raystation

    Class II
  • Rayautoplan 1.0

    Class II
  • Raydose

    Class II

See all devices from Raysearch Laboratories AB →